Even at the highest dose of 2.4 mg, where the risk appears greatest, most patients tolerate the medication without developing this side effect
Hauser DN, Dukes AA, Mortimer AD, Hastings TG
The researchers found that patients who gained or maintained weight while on a GLP-1 receptor agonist were more likely to lose weight after switching to phentermine, with a median weight loss of around 3% in the year after GLP-1 discontinuation
Berbudi A, Khairani S, Tjahjadi AI
Since 2021, the story of GLP-1s has illustrated that scientific progress is rarely a straight line from hypothesis to patient access
The doctor may recommend treatments to manage the symptoms and monitor your childs vital signs